Recent Clinical Trials of mTOR-Targeted Cancer Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|6|1|24-35

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.6, Iss.1, 2011-01, pp. : 24-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials of Targeted Alpha Therapy for Cancer

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 3, 2008-09 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 3, 2007-09 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

By  

ORAL DISEASES, Vol. 21, Iss. 7, 2015-10 ,pp. : 815-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

By  

ORAL DISEASES, Vol. 1354-523X, Iss. 7, 2015-10 ,pp. : 815-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans

By Kamm Christoph  

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 637-650

Future Science

Access to resources Recommend Favorite